Press Release

Photography of a distributor in assay developmentPress Release

VitamFero announces that Clean Cells has created a cell bank for its Toxo KO vaccine strain  

 

Following its recent industrial partnership signed with a world leader for animal health to develop its bovine neosporosis vaccine candidate, VitamFero, working with Clean Cells, has just successfully completed setting up and securing a master seed bank for its Toxo KO ovine toxoplasmosis vaccine strain.
Angers, France: March 19, 2018

VitamFero, a French veterinary biotech company specialized in creating and developing next-generation vaccines, is producing its vaccine candidates on Vero cells and is already able to capitalize on a master cell bank prepared and controlled under GMP conditions by Clean Cells.

Toxo KO, the live attenuated vaccine parasite strain aiming to protect lambs against congenital toxoplasmosis, is also the basis for other preventative treatments developed by VitamFero, including its multi-recombinant vaccines. These multi-recombinant vaccines are designed to prevent selected bacterial, viral or parasitic infections in livestock leading to major economic losses. Unlike the other live attenuated vaccines for veterinary use, this Toxo KO strain is currently the only one whose natural virulence has been attenuated by genetic editing. Such attenuation of virulence with a fully documented genetic signature eliminate the risk of restoration the virulence following environmental pressure.

The availability of a fully quality controlled master seed bank (MSB) for its Toxo KO strain allows VitamFero to continue developing its ovine toxoplasmosis vaccine (VFO-TX-02) in line with the operational schedule defined jointly with its Australian partner, Bioproperties.

For more information, please download the Press Release

VitamFero : www.vitamfero.com

Catalogue Test

Our News & Events

  • Clean Cells’ Events

    Meet with Clean Cells. In the second quarter, join the Clean Cells’ team at: VIRAL SAFETY FOR BIOLOGICS, BIOMED…

  • Press Release

    VitamFero announces that Clean Cells has created a cell bank for its Toxo KO vaccine strain.

  • Clean Cells’ Events

    In the first quarter,
    join the Clean Cells’ team at:
    CELL & GENE THERAPY WORLD

  • New collaborative project “HybridADCC”

    Capitalising on the success of Premium ADCC, Clean Cells will provide its skills in cell culture and in the development of…

  • ACTIP MEETING

    Thursday 30 Nov, in Nantes, the ACTIP (Animal Cell Technology Industrial Platform) organized a meeting for its members.

  • Boost Your Brain

    “Boost your Brain” aim at providing information to our personnel about diverse topics concerning the biopharmaceutical field…

  • Clean Cells’ Events

    In the third quarter, join the Clean Cells’ team at : Regmed Europe and NLSDays

  • Clean Cells’ Events

    Meet with Clean Cells. In the first quarter, join the Clean Cells’ team at the Centennial Celebration of Bacteiophage research…

  • Clean Cells’ Events

    Meet with Clean Cells. In the first quarter, join the Clean Cells’ team at :
    BIOTECH SHOWCASE 2017…

  • Clean Cells’ Events

    Meet with Clean Cells. In the fourth quarter, join the Clean Cells’ team at :
    WORLD VACCINE CONGRESS…

  • Clean Cells’ Events

    In the third quarter, join the Clean Cells’ team at : ANTIBODY INDUSTRIAL SYMPOSIUM, EMBO CONFERENCE, BIOREGATE FORUM…

  • Clean Cells’ Newsletter

    Clean Cells is doing every to propose solutions that allow them to follow daily its activities. This is the reason why…

  • Of phages and men

    Clean Cells, as an authorized pharmaceutical facility, is now in position to offer its customers a wide panel of services for drug…

  • Clean Cells Tunes into Gene Therapy

    Clean Cells expands its service portfolio by tuning into gene therapy products since the beginning of 2015…

  • Clean Cells joins Come In Vendée

    Artists, merchants and companies from the Vendée that will unit to participate to the next Vendée Globe?…